Skip to content
Toggle main navigation
Home
More
Open dropdown to see remaining menu items
Log in
Enhanced control of iPS cell critical quality attributes through analytical characterisation, by John Barlow, PhD
Published on September 30, 2024
Continue reading on website
Other news
Blog: Digital Brand Refresh – The launch of a dynamic, new abzena.com
September 26, 2024
We are pleased to share with our customers that our new, brand refreshed, website is live. Here is a brief overview on some differences that you’ll find as you navigate our new website…At first glance, we’ve given our website a fresh, modern look that’s in line with our overall brand refresh and our mission as an organization to ‘Move Medicine Forward’. Beyond that and in keeping with our moving f
Pharma’s future: More with less
October 1, 2024
2023 saw the biopharmaceutical industry spend a record $300bn on R&D activities, reinvesting approximately 30% of prescription revenues to secure the next generation of therapies. Yet, recent weeks have seen falling valuations and stark anecdotes from contract research organizations as their main client base – large pharma companies – have tightened the belt on early […]